Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening. Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade astrocytoma are among the worst. In addition, physicians in the department work with neurosurgeons, radiation oncologists, neuropathologists and neuroradiologists to plan a course of treatment that is unique and comprehensive for each patient. The physicians treat patients that are battling central nervous system tumors, including gliomas (glioblastoma multiforme, astrocytoma, brainstem glioma,  ependymoma, oligodendroglioma), meningioma, vestibular schwannoma, central nervous system lymphoma, metastatic disease to the brain and spine, or primary spinal cord tumors. 

Physicians in Neuro-Oncology also specialize in genetic disorders. Neurofibromatosis is a genetic disorder that causes tumors to grow in the nervous system. The Neurofibromatosis Working Group provides exceptional care and treatment for patients with the disorder. It also works to translate laboratory advances into improved treatments for these patients. The group is a collaborative effort that includes Neuro-Oncology, Neurosurgery, and Investigational Cancer Therapeutics. The Neruo Forum 2023 is a platform of skilled and experienced physicians participates in a multidisciplinary approach to cancer care, neurologists treat central and peripheral nervous system conditions that may affect cancer patients, while neuropsychologists diagnose and treat cognitive and behavioral effects of cancer, or help patients learn ways to minimize cancer's impact on their quality of life.